Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
FDA approves Guardant Health’s Shield blood test as first primary CRC screening option
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance…
Sionna and AbbVie deal can redefine cystic fibrosis therapeutics: GlobalData
Sionna Therapeutics secures exclusive global rights to develop and commercialise advanced CF compounds, strengthening its pipeline…
Shares of Japan’s Eisai tumble after EU rejects Alzheimer’s drug
EU regulator cites brain swelling risks, impacting Eisai and Biogen, and sparking concerns over global sales and market perception…
FOPE and PharmaState Academy complete second PULSE session on pharmaceutical quality systems
The session focused on quality systems, with over 900 participants and 2000 social media views
Romaco develops new ERS system, reduces upto 50 per cent energy consumption
Romaco Tecpharm's new system for tablet coaters cuts thermal energy use by half and lowers outlet air temperature
Dr Reddy’s receives positive CHMP opinion for biosimilar Rituximab candidate in European markets
Dr Reddy's Rituximab biosimilar DRL_RI (ITUXREDI) progresses towards European approval with EMA CHMP endorsement
Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at…
Inspection conducted from July 17-26, 2024, concludes affirming facility’s compliance with GMP standards
Phase III post-marketing commitment study data paves way for usage of Paratek’s Nuzyra in other…
New data confirms Nuzyra’s non-inferiority to moxifloxacin and highlights its potential for broader use in treating various…
US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug
Regulator highlights risks of dosing errors and adverse events, urges healthcare providers to ensure correct syringe use and…
Navigating the IPR maze: India’s pharmaceutical challenge
Dr Deevanshu Shrivastava, Associate Dean, GD Goenka University, elaborates on the crucial role of IPR in India pharma Inc’s…